Key result
Radiation exposure during C-arm-assisted vascular surgery resulted in a mean patient effective dose of 6.2 mSv and an estimated operator cancer incidence risk of 1 in 42 persons.
Why the study?
What is the radiation exposure dose and estimated carcinogenic risk for patients and staff during C-arm-assisted vascular surgical operations?
Observational (n=71)
No
What is the radiation exposure dose and estimated carcinogenic risk for patients and staff during C-arm-assisted vascular surgical operations?
C-arm-assisted vascular surgery exposes patients and staff to significant radiation, highlighting the need for strict radiation protection protocols to minimize carcinogenic risk.
Estimated risks underscore caution in C-arm vascular procedures; observational data leaves open optimal mitigation strategies.
The objective of this study was to identify the radiation exposure dose of patients, as well as staff caused by fluoroscopy for C-arm-assisted vascular surgical operation and to estimate carcinogenic risk due to such exposure dose. The study was conducted in 71 patients (53 men and 18 women) who had undergone vascular surgical intervention at the division of vascular surgery in the University Hospital from November of 2011 to April of 2012. It had used a mobile C-arm device and calculated the radiation exposure dose of patient (dose–area product, DAP). Effective dose was measured by attaching optically stimulated luminescence on the radiation protectors of staff who participates in the surgery to measure the radiation exposure dose of staff during the vascular surgical operation. From the study results, DAP value of patients was 308.7 Gy cm2 in average, and the maximum value was 3085 Gy cm2. When converted to the effective dose, the resulted mean was 6.2 m Gy and the maximum effective dose was 61.7 milliSievert (mSv). The effective dose of staff was 3.85 mSv; while the radiation technician was 1.04 mSv, the nurse was 1.31 mSv. All cancer incidences of operator are corresponding to 2355 persons per 100,000 persons, which deemed 1 of 42 persons is likely to have all cancer incidences. In conclusion, the vascular surgeons should keep the radiation protection for patient, staff, and all participants in the intervention in mind as supervisor of fluoroscopy while trying to understand the effects by radiation by themselves to prevent invisible danger during the intervention and to minimize the harm.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2013) conducted an observational in Vascular surgical intervention (n=71). Radiation exposure from fluoroscopy was evaluated on Radiation exposure dose and estimated carcinogenic risk. Radiation exposure during C-arm-assisted vascular surgery resulted in a mean patient effective dose of 6.2 mSv and an estimated operator cancer incidence risk of 1 in 42 persons.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: